This lower CD99 expression on T cells in male MS patients led to a loss of the sex-specific expression pattern in the CSF on CD4+ T cells and to a lesser pronounced sex-specific difference in CD8+ T cells in disease context. The gene discussed is CD8A; the disease is myeloid sarcoma.